1. Adverse events after use of compounded semaglutide

   News item 17 June 2023 Pages: 1 - 1

2. Antipsychotics: constipation common side effect, especially with clozapine

   News item 17 June 2023 Pages: 2 - 2

3. Avoiding oxytocin medication errors: ISMP recommendations

   News item 17 June 2023 Pages: 3 - 3

4. Etoposide-related electrolyte imbalance

   News item 17 June 2023 Pages: 4 - 4

5. Ocular NSAIDs: risk of corneal melting

   News item 17 June 2023 Pages: 5 - 5

6. RAS inhibitors: additional precautions for use in women of child-bearing potential issued in Japan

   News item 17 June 2023 Pages: 6 - 6

7. SGLT2 inhibitors: risk of polycythaemia

   News item 17 June 2023 Pages: 7 - 7

8. Updated safety and prescribing information for clomifene

   News item 17 June 2023 Pages: 8 - 8

9. Warning against use of EVE apronalide products

   News item 17 June 2023 Pages: 9 - 9

10. ADRs underreported to UK Yellow Card Scheme

    Clinical study 17 June 2023 Pages: 10 - 10

11. Concurrent medication frequently interacts with antiepileptic drugs

    Clinical study 17 June 2023 Pages: 11 - 11

12. Third mRNA COVID-19 vaccine dose well tolerated in infants and young children

    Clinical study 17 June 2023 Pages: 12 - 12

13. Other adverse reaction research

    News item 17 June 2023 Pages: 13 - 13

14. Aciclovir

    Case report 17 June 2023 Pages: 14 - 14

15. Aciclovir

    Case report 17 June 2023 Pages: 15 - 15

16. Ad26.cov2-s/immune-globulin

    Case report 17 June 2023 Pages: 16 - 16

17. Adalimumab

    Case report 17 June 2023 Pages: 17 - 17

18. Adalimumab

    Case report 17 June 2023 Pages: 18 - 18

19. Adalimumab/isotretinoin

    Case report 17 June 2023 Pages: 19 - 19

20. Aflibercept/brolucizumab/ranibizumab

    Case report 17 June 2023 Pages: 20 - 20

21. Albumin-human/tolvaptan

    Case report 17 June 2023 Pages: 21 - 21

22. Alcohol

    Case report 17 June 2023 Pages: 22 - 22

23. Alectinib

    Case report 17 June 2023 Pages: 23 - 23

24. Alectinib/crizotinib

    Case report 17 June 2023 Pages: 24 - 24

25. Alemtuzumab/fingolimod/methylprednisolone

    Case report 17 June 2023 Pages: 25 - 25

26. Alendronic-acid/bisphosphonates

    Case report 17 June 2023 Pages: 26 - 26

27. Allopurinol

    Case report 17 June 2023 Pages: 27 - 27

28. Amantadine/droxidopa

    Case report 17 June 2023 Pages: 28 - 28

29. Amiodarone

    Case report 17 June 2023 Pages: 29 - 29

30. Amiodarone

    Case report 17 June 2023 Pages: 30 - 30

31. Amiodarone/flecainide/sotalol

    Case report 17 June 2023 Pages: 31 - 31

32. Amitriptyline/duloxetine/gabapentin

    Case report 17 June 2023 Pages: 32 - 32

33. Amoxicillin/clavulanic-acid/enrofloxacin

    Case report 17 June 2023 Pages: 33 - 33

34. Anakinra

    Case report 17 June 2023 Pages: 34 - 34

35. Anastrozole/clomifene

    Case report 17 June 2023 Pages: 35 - 35

36. Andexanet-alfa/apixaban

    Case report 17 June 2023 Pages: 36 - 36

37. Anti-inflammatories

    Case report 17 June 2023 Pages: 37 - 37

38. Anti-inflammatories

    Case report 17 June 2023 Pages: 38 - 38

39. Antibacterials/sodium-bicarbonate/sodium-valproate

    Case report 17 June 2023 Pages: 39 - 39

40. Anticoagulants/antiplatelets/antivirals

    Case report 17 June 2023 Pages: 40 - 40

41. Antiepileptic-drugs

    Case report 17 June 2023 Pages: 41 - 41

42. Antifungals

    Case report 17 June 2023 Pages: 42 - 42

43. Antihistamines/carbamazepine/paracetamol

    Case report 17 June 2023 Pages: 43 - 43

44. Antineoplastics

    Case report 17 June 2023 Pages: 44 - 44

45. Antineoplastics

    Case report 17 June 2023 Pages: 45 - 45

46. Antineoplastics

    Case report 17 June 2023 Pages: 46 - 46

47. Antineoplastics

    Case report 17 June 2023 Pages: 47 - 47

48. Antineoplastics

    Case report 17 June 2023 Pages: 48 - 48

49. Antineoplastics

    Case report 17 June 2023 Pages: 49 - 49

50. Antineoplastics

    Case report 17 June 2023 Pages: 50 - 50